Potential Glaxo loss could be Lilly’s gain

Please subscribe to IBJ to decode this article.

tch ooat bti nm l$unc rhhDptaogeaE j einy oFo miztlcno 2riLde utt=mtkaeoatte CddonhAro in nfeoaile>fi.umneo s fnd siosncotsiaisl er o i t .tl eili rof c capiysdi ededtfsaatolf rse 2sennfi a

Smpacodol ieeaDanb iailtedas o i Uopmfb alat eol d rsi i.ca hntsAu.eDyvlt odGt errtr l arkg Fore At.t elaiotm Bvg,dmssvdh

teevaak aetlyxolhtmi a drsG$itba t na-Sola eSa n. . l d les nacronA ai t ,mko ladehkrUntp o btcat s dd een anijKigbiaouetelmsre 2y na ihuaeea,inrp,.Main ssbatsa stuihidin hscdtrttlayltrrkren eibhcstiefeBap ihs ew ii earmkgsrian

h ea i4tSolqe2 oifsldte2Lelc, ek dfdlaatt itultr2Ar etatwdp s 5 praD $mao-ne ylth-y .n, ihsr eolnhge s iLtlPooceiiibiilaaoesnlmf,snycme m nasei eB1 a b eaavyeliB itsenurclnarc craSpeyweat. Aos5lltle

She. s ,adckai aot , ladho ne nCeos aas eca iyoeiU cl cpk rm otfardootatd rAtwoeAelspniarieLat rhotyrlJi/ntimf asetePvscte